Clinical Utility Study Indicates Potential for TruGraf™ Test to Replace Surveillance Biopsies in Kidney Transplant Recipients with Stable Renal Function
November 28, 2017 11:51 ET
|
Transplant Genomics Inc.
Mansfield, Nov. 28, 2017 (GLOBE NEWSWIRE) -- MANSFIELD, MA – Transplant Genomics Inc. (TGI), a molecular diagnostics company committed to improving organ transplant outcomes, has published a...
Molecular Diagnostics Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2012–2022
November 22, 2017 05:23 ET
|
Crystal Market Research
LAS VEGAS, Nov. 22, 2017 (GLOBE NEWSWIRE) -- The Molecular Diagnostics Market was worth USD 2.50 billion in the year 2012 and is expected to reach approximately USD 6.05 billion by 2022, while...
Study Shows TruGraf Blood Test Enables Non-invasive Detection of Immune Quiescent Kidney Transplant Recipients
October 24, 2017 09:24 ET
|
Transplant Genomics Inc.
Mansfield, Oct. 24, 2017 (GLOBE NEWSWIRE) -- MANSFIELD, MA – Transplant Genomics Inc. (TGI), a molecular diagnostics company committed to improving organ transplant outcomes, announces a publication...
Internal Sample Preparation, Small Size and Rapid Results Differentiate the FireflyDX Systems, says Lyle Probst During BioWatch Panel
September 19, 2017 08:00 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Sept. 19, 2017 (GLOBE NEWSWIRE) -- One of the biggest barriers to delivering rapid diagnosis and care during a biological outbreak is about to be eliminated, said Lyle L. Probst,...
Admera Health Expands Asian Footprint with Three Strategic Partnerships
September 12, 2017 11:05 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., Sept. 12, 2017 (GLOBE NEWSWIRE) -- Today, Admera Health announced agreements expanding Admera’s portfolio of molecular diagnostics to Asia, including but not limited to...
OmniSeq and LabCorp Sign Exclusive Distribution Agreement and Series B Funding Commitment
August 21, 2017 08:01 ET
|
OmniSeq
BUFFALO, N.Y., Aug. 21, 2017 (GLOBE NEWSWIRE) -- OmniSeq, Inc., a molecular diagnostics subsidiary of the Roswell Park Cancer Institute, announced today that it has entered into an exclusive...
New York Medical College and Touro College of Pharmacy Team to Offer Pharmacogenomics CME Course Sponsored by Admera Health
August 08, 2017 09:59 ET
|
Admera Health, LLC
VALHALLA, N.Y. and SOUTH PLAINFIELD, N.J., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Today, New York Medical College and Touro College of Pharmacy announced the wider availability of their joint Continuing...
Columbia University Medical Center’s Center for Biomedical Informatics Collaborates with Admera Health in a Clinical Study, Evaluating Pharmacogenetics in Psychiatric Medications
July 25, 2017 19:00 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., July 25, 2017 (GLOBE NEWSWIRE) -- Admera Health, an advanced molecular diagnostic laboratory, has been selected by Columbia University Medical Center’s Center for Biomedical...
OmniSeq Launches Immune Report Card
June 14, 2017 08:05 ET
|
OmniSeq
BUFFALO, N.Y., June 14, 2017 (GLOBE NEWSWIRE) -- OmniSeq, an innovation of Roswell Park Cancer Institute, announced today the commercial launch of Immune Report Card SM, the first immune profiling...
Internationally Recognized Pharmacogenomic Expert Dr. Howard McLeod Joins Admera Health’s Advisory Board
May 17, 2017 09:13 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., May 17, 2017 (GLOBE NEWSWIRE) -- Advanced Molecular Diagnostics company, Admera Health, (www.admerahealth.com) announced today the appointment of Howard McLeod, PharmD to its...